ADARx Pharmaceuticals, Inc.
ADRX나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
2건
최근 2026.10.16
90일 내부자 순매수
+1,228억원
순매수
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 33건
- US미국대량보유(5%)중요도 보통2026.10.16SCHEDULE 13G · Beneficial ownership report (13G)
ADARx Pharmaceuticals, Inc.ADRX
SCHEDULE 13G · 2026.10.16
- US미국대량보유(5%)중요도 높음2026.10.05SCHEDULE 13D · Beneficial ownership report (13D)
ADARx Pharmaceuticals, Inc.ADRX
SCHEDULE 13D · 2026.10.05
- US미국대량보유(5%)중요도 높음2026.10.02SCHEDULE 13D · Beneficial ownership report (13D)
ADARx Pharmaceuticals, Inc.ADRX
SCHEDULE 13D · 2026.10.02
- US미국대량보유(5%)중요도 보통2026.10.01SCHEDULE 13G · Beneficial ownership report (13G)
ADARx Pharmaceuticals, Inc.ADRX
SCHEDULE 13G · 2026.10.01
- US미국임원·주요주주 소유중요도 높음2026.09.304 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.30
- US미국임원·주요주주 소유중요도 높음2026.09.304 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.30
- US미국임원·주요주주 소유중요도 높음2026.09.304 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.30
- US미국임원·주요주주 소유중요도 높음2026.09.294 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.29
- US미국임원·주요주주 소유중요도 낮음2026.09.294 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.29
- US미국임원·주요주주 소유중요도 높음2026.09.294 · Statement of changes in beneficial ownership
ADARx Pharmaceuticals, Inc.ADRX
Form 4 · 2026.09.29